Teva, Israel's Biggest Country, In Opioid Legal Trouble
Israel's Teva gives upbeat outlook as restructuring proceeds
Jewish Values Investors JLens Target Israeli Company
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Israel's Teva gets China's green light for Huntington's treatment | The Times of Israel
Teva Pharmaceuticals - Wikipedia
Israeli drug giant Teva to move offices to Tel Aviv - Israel News - The Jerusalem Post
Teva Pharmaceuticals Lays Off Half Its Israeli Workers
Teva's Recovery Hopes Mired in Staggering Antitrust Lawsuit, $26.7 Billion Debt | The Jewish Press - JewishPress.com | David Israel | 7 Iyyar 5779 – May 12, 2019 | JewishPress.com
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Israel's Teva donating potential COVID-19 treatment to US hospitals - ISRAEL21c
Teva sheds logistics center for $127M after 2 about-faces | Fierce Pharma
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State - CNN
Union calls strike over thousands of expected Teva layoffs | The Times of Israel
Teva Restructuring Coming Together, Rebuilding Confidence in the Company | BioSpace
Teva Faces Rocky Path to Recovery After Debt | Fortune
Teva bought the pharm, and now it may have bought the farm | The Times of Israel
Teva Forecasts Growth After Expected Actavis Deal Closes | Stock News & Stock Market Analysis - IBD
Israeli drugmaker Teva to cut quarter of global work force | Arab News
Parsippany-based Teva reaches $225M opioid settlement with Texas - NJBIZ
Teva to market, distribute medical cannabis inhaler in Israel | Israel National News - Arutz Sheva
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at their tablet production plant in Jerusalem, on Monday, October 21, 2019. The Israeli drug manufacturer Teva's
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
